Table 3.

Cox regression analyses for cardiovascular outcomes.

	Univariable (unadjusted) HR (95% CI) P-value	Multivariable (adjusted) HR (95% CI) P-value
Age	1.05 (0.96–1.14) 0.26	1.08 (0.97–1.19) 0.13
Gender	1.21 (0.60–2.43) 0.59	0.86 (0.40–1.83) 0.69
BMI	1.01 (0.89–1.14) 0.85
Hypertension	0.84 (0.38–1.82) 0.66
Diabetes Mellitus	0.46 (0.19–1.08) 0.07
Ferritin	1.00 (0.99–1.00) 0.09
WBC	1.07 (1.02–1.14) 0.03	1.01 (0.94–1.09) 0.64
Fibrinogen	1.00 (0.99–1.00) 0.23
D-dimer	1.20 (1.16–1.28) <0.001	1.13 (1.10–1.22) 0.003
Troponin	1.08 (1.04–1.11) <0.001	1.01 (0.99–1.02) 0.18
CRP	1.01 (1.00–1.02) 0.001	1.01 (0.99–1.04) 0.22
ESR	1.01 (0.99–1.03) 0.34
ICU	1.74 (1.33–2.89) <0.001	4.70 (1.59–13.86) 0.001
HQ	0.98 (0.96–1.02) 0.61
Oseltamivir	1.24 (0.35–2.78) 0.54
Azithromycin	1.00 (0.99–1.01) 0.22
Clarithromycin	0.89 (0.58–1.34) 0.40
Moxifloxacin	0.33 (0.10–1.19) 0.15
Ceftriaxone	0.55 (0.26–1.49) 0.38

HR, hazard ratio; CI, confidence interval; BMI, body mass index; WBC, wight blood cell; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ICU, intensive care unit; HQ, hydroxychloroquine. Biomarkers refer to values during hospitalization.